Copyright
©The Author(s) 2015.
World J Clin Cases. Apr 16, 2015; 3(4): 360-367
Published online Apr 16, 2015. doi: 10.12998/wjcc.v3.i4.360
Published online Apr 16, 2015. doi: 10.12998/wjcc.v3.i4.360
Sugammadex (dose) | Group A (n = 16) | Group B (n = 16) | P-value | ||
Age (yr) | 43.6 | (SD 12.01) | 47.1 | (SD 14.18) | 0.46 |
Weight (kg) | 65.5 | (SD 11.22) | 60.9 | (SD 10.62) | 0.25 |
Height (cm) | 163.2 | (SD 4.76) | 160.1 | (SD 5.91) | 0.12 |
BMI (kg/m2) | 24.1 | (SD 3.56) | 23.2 | (SD 3.65) | 0.47 |
Intervention (time-minute) | 95.2 | (SD 26.91) | 94.7 | (SD 30.02) | 0.96 |
ASA (1-2) | 1.4 | (SD 0.51) | 1.2 | (SD 0.48) | 0.28 |
ASA 1a | n = 9 | (56.25%) | n = 12 | (75.00%) | 0.23 |
Group A (n = 14) | Group B (n = 14) | |||||||
Mean | Median | Mean | Median | Assumed calculated interval (increased of 0% to 50% of median in group B) | Estimated difference median by Hodges-Lehmann estimator | 95%CI | ||
TOF ratio 0.9 | 118.8 | 129 | 96.6 | 105 | 0 to 52.5 | 24 | 0 to 45 | Differences not assumed |
TOF ratio 0.8 | 96.7 | 101 | 80.1 | 82.5 | 0 to 43.7 | 18 | -5 to 39 | Assumed |
TOF ratio 0.7 | 78.4 | 90 | 66.3 | 65 | 0 to 32.5 | 10 | -10 to 35 | Assumed |
Adverse events | Group A | Group B |
Arterial hypertension | 0% | 0% |
Arterial hypotension | 0% | 0% |
Bradycardia | 0% | 0% |
Cough | 0% | 0% |
Headache | 0% | 0% |
Nausea | 6.20% | 6.20% |
Pain | 6.20% | 6.20% |
Residual neuromuscular blocking | 0% | 0% |
Vomiting | 0% | 0% |
Others | 0% | 6.20% |
- Citation: Mesa DS, Fayad MF, Arviza LP, Ruiz VDV, Carreño FC, Tamargo LA, Díaz MA, Montes SFP. Efficacy of different doses of sugammadex after continuous infusion of rocuronium. World J Clin Cases 2015; 3(4): 360-367
- URL: https://www.wjgnet.com/2307-8960/full/v3/i4/360.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v3.i4.360